The results proved the utility of research of cardiac specific biomarkers for early detection of anthracyclines-induced cardiotoxicity, the correlation with stage of disease treatment and cumulative dose and the suggestive Echo changes for cardiac involvement, the favorable cardioprotector effect of enalapril in prevention and treatment of this cardiotoxicity.
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"Grey Zone" of 40-50% ejection fraction in ambulatory patient with Heart Failure. Who are these patients? Lessons from the DEVENIR study Alain Cohen Solal (1), Patrick Assyag (2), Pierre Clerson (3), Christine Contre (4), Maxime Guenoun (5), Pascal Poncelet (5), Jean Francois Thebaut (5), Leurs Irina (4) (1) LARIBOISIERE, Paris, SAINT ANTOINE, Paris, ORGAMETRIE, Roubaix, MENARINI, Rungis, CNCF, Paris, France Rationale: Heart Failure (HF) with preserved LVEF has been individualized in recent years as a specific entity, with different mechanisms, special baseline characteristics, a poor prognosis and no clearly recognized treatment. LVEF cut-off has not been clearly defined. If 50% is generally accepted as a rather specific cut-off, there remains a « grey zone » of patients with EF between 40% and 50% not clearly individualized between reduced and preserved LVEF.
Objectives: to describe the characteristics of patients with LVEF belonging to the "grey zone" and to compare these patients to those with either reduced or preserved LVEF.
Methods:
Cross sectional observational survey with retrospective collection of data at hospital discharge. Patients must have been diagnosed with HF and have been hospitalized for HF within the previous 18 months. Patients are classified according to the LVEF at hospital discharge.
Results: 412 French outhospital cardiologists included 1 452 patients with the inclusion criteria.
Conclusion: This is the first French survey in patients managed by cardiologists after hospital discharge for HF. Cardiologists mainly care for patients with low LVEF. Overall, the profile of patients with LVEF 40-50% at hospital discharge is closer to the < 40% than to the >50% LVEF group. Characteristics according to LVEF at discharge (n=1 408) are displayed below. 
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Results:
The HF occupies 14% of hospitalizations. The mean length of stay was 14 ± 3.1 days. The mean age was 58 ± 11.5 years. Men were mostly represented with a ratio H / F = 3.5. The main cardiovascular risk factor was smoking (55%) followed by hypertension (40%) and diabetes (35%). Dyspnea was the main symptom reported in 91% of the cases. The clinical presentation was that of left (65%), right (22%) and global(23%) HF. Among electric signs, we found Atrial fibrillation (30%), a Q-wave (58%) and left ventricular hypertrophy (28%). the chest x-ray showed a cardiomegaly (89%) and signs of pulmonary overload (86%). Biology showed electrolyte abnormalities in half of the cases, renal failure (35%) and anemia (28%). In echocardiography, the mean left ventricular ejection fraction (LVEF) was 34.5 ± 5.4%. LVEF was > 45% for 26% of patients. 134 patients underwent a coronary angiography which objectified coronary damage in 84% of the cases. The main causes were ischemic heart disease (42%), valvular heart disease(24%) and hypertension (13%). most used drugs were angiotensin converting enzym inhibitors and diuretics. 21% of patients underwent a mitral valve replacement with mechanical prosthesis. Among patients with coronary artery disease, 33% were revascularized by coronary bypass (21%) and coronary angioplasty (12%). Cardiac resynchronization was performed for 19 patients using implantable automatic defibrillator for 3 of them.Hospital mortality was 10%.
Conclusion:
The main features of this population is the relatively young age, male predominance, ischemic heart disease as a leading cause and low rate of HF with preserved systolic function. 
